for the CONSORT Group*

pharmacologic treatments presents specific challenges that are not adequately addressed in trial reports. Objective: To develop an extension of the CONSORT (Consoli-dated Standards of Reporting Trials) Statement for trials of non-pharmacologic treatments. Design: A consensus meeting was organized to develop an exten-sion of the CONSORT Statement that addresses randomized trials of nonpharmacologic treatments. To prepare for the meeting, a survey was conducted to identify the specific issues for discussion. Setting: Consensus meeting in Paris, France. Participants: A total of 33 experts attended the meeting. The experts were methodologists (n 17); surgeons (n 6); editors (n 5); and clinicians involved in rehabilitation (n 1), psycho-therapy (n 2), education (n 1), and implantable devices (n 1)